Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0160-2024

Drug recall · January 3, 2024

ANORO ELLIPTA recall

Why: Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured by GlaxoSmithKline Durham, NC 27701. NDC 0173-0869-10

Lots / codes

Lot #: 7Y9S. Exp June 2025

Quantity
67,508 inhalers
Company
GlaxoSmithKline LLC, Durham, NC
Distribution
Distributed Nationwide in the USA and Puerto Rico.
Initiated
December 12, 2023 · Voluntary: Firm initiated
Classified
December 22, 2023
Reported
January 3, 2024
Ended
September 12, 2024
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Anoro

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.